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Induction of Rapid T Cell Activation
and Tolerance by Systemic Presentation
of an Orally Administered Antigen
Although T cells producing inhibitory cytokines after oral
feeding of antigens have been demonstrated in vitro
(Chen et al., 1994, 1996), the migration of these cells
from the gut to the peripheral lymphoid organs and the
in vivo regulation of effector functions throughcytokines
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have not been established.Stanford University
Since host animals do not normally react to ingestedStanford, California 94305
proteins, it is commonly assumed that the gut-associ-
ated lymphoid tissues are responsible for the induction
of oral tolerance. Although immunosuppressive cyto-Summary
kines such as transforming growth factor b (TGFb) and
interleukin-10 (IL-10) are indeed found abundantly in theTo understand how orally introduced antigen regu-
intestine, it is not really clear where the major sites oflates peripheral immune responses, we fed cyto-
tolerance induction are located. It has been demon-chrome c protein to mice transgenic for the b chain
strated that some proteins, intact or partially degraded,of a cytochrome c±specific TCR and followed the anti-
can enter directly from the gut lumen into the bloodgen-specific T cell responses with a cyt c/I-Ek tetramer
stream (Swarbrick et al., 1979; Bruce and Ferguson,staining reagent. We find that within 6 hr of cyto-
1986; Peng et al., 1990). Thus, orally administered anti-chrome c administration, antigen-specific systemic T
gen can travel systemically and induce tolerance atcell activation is induced, and spleen cells gain the
site(s) other than the gut-associated lymphoid tissues.ability to stimulate cytochrome c±specific T cell re-
Distinguishing between these possibilities requires thesponses. Feeding multiple low doses of cytochrome c
analysis of early antigen-specific T cell responses; how-down-regulates the systemic immune response, which
ever, no study earlier than 24 hrafter antigen administra-can be correlated with a reduction of antigen-specific
tion has been reported.T cells and not with immune deviation. These results
An understanding of how orally introduced proteinsuggest that systemic distribution of antigen contrib-
antigens regulate peripheral immune responses re-utes significantly to oral tolerance induction.
quires the ability to follow antigen-specific T cells at all
stages of the response, but the methods of trackingIntroduction
these cells should be independent of their activation
outcomes. Thus, the classical method of stimulatingFeeding protein antigen to down-regulate systemic im-
bulk cultures of spleen or lymph node cells with themune responses is a recognized method of inducing
appropriate antigen or the widely used limiting dilutionperipheral tolerance (reviewed by Weiner et al., 1994;
assay would be of limited value.Mowat and Viney, 1997; Weiner, 1997). Recently, there
To overcome these difficulties, experimental systemshas been renewed interest in the potential of this method
using mice transgenic for particular T cell receptorsfor modulating autoimmune, inflammatory, and allergic
(TCR) have been studied (Chen et al., 1995, 1996; Marthdisorders.
et al., 1996; Whitacre et al., 1996; Lanoue et al., 1997).Despite the long interest inoral tolerance (Wells, 1911;
Although in many of these systems an altered T cellChase, 1946), the parameters that govern its induction
response induced by orally administered antigen canremain poorly defined, and the mechanism by which it
be inferred by in vitro assays, peripheral hyporespon-occurs remains controversial. While reports show that
siveness has been difficult to demonstrate.oral administration of large amounts of protein anti-
Another approach is to use mice adoptively trans-gens (usually more than 10 mg per mouse) can induce
ferred with TCR transgenic T cells. However, in the twoantigen-specific T cell inactivation (anergy) or deletion
studies using the same experimental system (transfer-(reviewed by Weiner et al., 1994; Weiner, 1997), this
ring D011.10 TCR transgenic T cells into BALB/c mice),regimen does not lead to oral tolerance in some experi-
different mechanisms of tolerance induction and differ-mental systems (Lanoue et al., 1997), and, as reported
ent results regarding the ability of the transferred cellsrecently, feeding a high dose of hen egg ovalbumin
to home to the gut were reported (Van Houten and Blake,(OVA) can even prime specific cytolytic T cell responses
1996; Chen et al., 1997).in mice (Blanas et al., 1996). Repeated feeding of a
An ideal way to follow a specific T cell population isrelatively small amount of antigen (usually between 0.05
to use the antigenic ligand as the probe. This approachand 5 mg per mouse) also induces tolerance. In these
has been used successfully for B cells, but it is morecases, active suppression by regulatory T cells induced
difficult for T cells because of the low-affinity interac-in the gut has been suggested to be the major mecha-
tions between the TCR and its peptide/major histocom-nism (reviewed by Weiner et al., 1994; Weiner, 1997).
patibility complex (MHC) ligand (Davis and Chien, 1993).
Recently, we have generated a series of peptide/MHC³To whom correspondence should be addressed (e-mail: chien@
tetramer staining reagents by multimerizing peptide/leland.stanford.edu).
MHC complexes in an oriented manner such that two§These authors contributed equally to this work.
or more TCRs on a T cell can be bound at one time. This‖ Present address: Department of Microbiology and Immunology,
Emory University, Atlanta, Georgia 30322. effectively lowers the dissociation rate of the multimeric
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peptide/MHC to the TCR and allows the multimer to be
used as a staining reagent. This approach has been
used successfully to stain T cells specific for HIV gag
and pol epitopes (in the context of human leukocyte
antigen A2) from the blood of HIV-infected individuals
(Altman et al., 1996).
Here, we report the development of a staining reagent
for cytochrome c (cyt c)±specific T cells and studies
using this reagent to follow the early activation and late
effector events of these T cells in mice fed with pigeon
Figure 1. Cyt c/I-Ek Tetramer Staining of Spleen Cells from 5C.C7cyt c protein. To facilitate detection, we used mice
ab TCR, 5C.C7 b-chain TCR Transgenic, and B10.BR Mice
transgenic for the TCR b chain of the 5C.C7 T cell clone
Spleen cells (1 3 106) from 5C.C7ab TCR (left), 5C.C7 b-chain TCR
(Jorgensen et al., 1992; Fazekas de St. Groth et al., transgenic (middle), and B10.BR mice (right) were incubated with
1992), which recognizes cyt c in context of I-Ek MHC the cyt c/I-Ek tetramer, anti-CD4, and anti-B220. Plots display CD4
class II molecules. These mice have an elevated fre- and tetramer staining of viable B2202 cells. The tetramer-positive
cells are boxed, with the percentage of tetramer1/CD41 cells indi-quency of cyt c±specific T cells (between 3% and 5%
cated in each plot.of total CD41 cells without immunization; see Results).
Although this frequency is higher than the frequency in
normal mice (around 1 in 105) (McHeyzer-Williams and
stain T cells from 5C.C7 ab TCR transgenic mice butDavis, 1995), it is comparable with that of T cells re-
not from B10.BR mice. As shown in Figure 1, the cytsponding to a foreign MHC haplotype and may not be
c/I-Ek tetramer stains approximately 75%±80%, 3%±5%,very different from some autoimmune disease models
and less than 1% of CD41 T cells from 5C.C7 ab TCRthat exhibit a spontaneously high frequency of autoreac-
transgenic mice, 5C.C7 TCRb transgenic mice, andtive T cells. These mice appear to have normal T cell
B10.BR mice, respectively. In the 5C.C7 TCRb trans-development and can generate immune responses to a
genic mice, only the tetramer-positive but not the nega-diverse set of antigens (data not shown). Histological
tive cells can mount cyt c±specific proliferative re-analysis (hematoxylin and eosin staining) of the small
sponses (data not shown). These tetramer-positive cellsintestine is also indistinguishable from that of normal
also stain positive for Va11. By polymerase chain reac-mice (data not shown).
tion (PCR) and DNA sequence analysis at the single cellWe found that mice fed with multiple low doses of cyt c
level, the TCRa chains are found to behighly selected for(0.5 mg, seven times) have a reduced number of cyt
both CDR3 length (eight amino acids) and the conservedc±specific T cells in both the spleen and the mesenteric
glutamic acid (E) and serine (S) residues at the junctionlymph nodes (MLN). In vitro cyt c±specific proliferation
(J. D. A. and M. M. D., unpublished data), typical of TCRaand IL-2 production are also reduced, with no evidence
chain sequences of cyt c±reactive T cells (Hedrick etfor the production of immunoregulatory types of cyto-
al., 1988; Jorgensen et al., 1992; McHeyzer-Williams andkines. Feeding a single dose of 0.5 mg of cyt c protein
Davis, 1995).can activate cyt c±specific T cells in the spleen and MLN
6 hr later, as determined by CD69 up-regulation. This
Multiple Feedings of Cyt c Decrease the Numbersuggests that orally administered cyt c is presented in
of Antigen-Specific T Cells in the Peripherythe peripheral lymphoid organs. Consistent with this
and Reduce T Cell Responses but Do Notnotion, splenic cells isolated from either 5C.C7 TCR
Alter T Cell Cytokine Profilesb chain transgenic or B10.BR mice fed with 5 mg of
Oral tolerance was induced by following the commonlycyt c 6 hr earlier can stimulate cyt c±specific transgenic
used protocol of low-dose feeding (Weiner et al., 1994).T cells in vitro. These results suggest that peripheral
Seven doses of 0.5 mg pigeon cyt c protein in phos-tolerance induced by food antigens may be very similar
phate-buffered saline (PBS) were administered intragas-to that induced by intravenous injection of soluble pro-
trically to 5C.C7 TCRb transgenic mice on alternateteins. This finding gives a biological context toperipheral
days. PBS, and in some experiments, 0.5 mg of hen eggtolerance induced by intravenous injection of soluble
lysozyme (HEL) in PBS, were similarly administered asproteins and suggests that food antigens may play a
controls. Mice were sacrificed and analyzed 2 days aftermore significant role in shaping the peripheral T cell
the last feed.repertoire than previously realized.
The number of cyt c/I-Ek tetramer-positive T cells in
both the spleen and lymph nodes of cyt c±fed mice isResults and Discussion
reduced as compared to those from mice fed with PBS
(Figure 2A and data not shown). Consistent with theCyt c/I-Ek Tetramer Stains Cyt
establishment of oral tolerance, the proliferative re-c±Specific T Cells
sponse is also reduced in spleen and lymph node cul-To follow cyt c±specific T cells, we made a cyt c/I-Ek
tures from cyt c±fed mice (Figure 2B and data nottetramer staining reagent. This involves engineering a
shown). In contrast, the proliferative response of spleenbiotinylation signal sequence at the C terminus of the
or lymph node cells to the superantigen staphylococcalI-Ea chain so that the cyt c/MHC heterodimer can be
enterotoxin A (which reacts with Vb31 cells) was unaf-biotinylated in vitro and coupled to a streptavidin±
fected by the feeding (data not shown).fluorophore conjugate in an oriented manner. The speci-
ficity of this reagent is demonstrated by its ability to Supernatants from in vitro cultures of spleen cells
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Figure 3. Oral Administration of Cyt c Alters the Distribution of Cyt
c±Specific T Cells in the Periphery
Mice were fed with 0.5 mg of cyt c in PBS and sacrificed 6, 24, 48,
and 72 hr later. Control mice were fed with PBS and sacrificed 24
or 72 hr later. Cells from spleen, MLN, PP, and peripheral blood
were analyzed by staining with cyt c/I-Ek tetramer (coupled with
phycoerythrin) and antibodies against CD69 (H1.2F3, fluorescein-
Figure 2. Oral Administration of Cyt c Reduces the Number, the coupled), CD4 (GK1.5, allophycocyanin-coupled), and B220 (RA3-
Proliferative Response, and the IL-2 Production of Cyt c±Specific T 6B2, cy-chrome-coupled). The percentage of tetramer-positive cells
Cells in the Periphery per CD41 cells was calculated after gating out B2201 and PI1 cells.
5C.C7 TCRb chain transgenic mice (8-week-old) were fed intragas- Points represent the values from individual mice; bars represent the
trically with 0.5 mg pigeon cyt c in PBS or PBS alone seven times arithmetic means. The significance of the differences between PBS-
on alternate days. Mice were sacrificed and analyzed 2 days after fed mice and PCC-fed mice was calculated using a two-tailed invari-
the last feed. ant Student's t test. All values except those for the PP and the 72
(A) Representative FACS analysis of spleen cells from mice fed with hr MLN were significantly different than the PBS-fed controls (p ,
PBS or cyt c, stained as described in Figure 1. Plots display CD4 0.05).
and tetramer staining with the tetramer-positive cells boxed and
the percentage of CD41 cells that are tetramer-positive indicated.
Similar reductions were observed in 23 of 24 cyt c±fed mice, as or migration of these T cells to other organs such as
compared to 24 PBS-fed mice. the liver or the gut. Regardless of the mechanism(s)
(B) Proliferative responses of cyt c-fed mice (open circles), PBS- involved, our results show that oral tolerance induced
fed mice (solid circles), and a B10.BR mouse (solid diamonds) from
by feeding multiple low doses of antigen is largely duea representative experiment are shown. Each curve represents data
to an effective reduction in the number of systemic anti-from a single mouse (error bars represent SD of duplicates). Re-
gen-specific T cells and not to a triggering of any largeduced proliferation in the spleen and/or MLN was observed in 33
of 35 cyt c±fed mice as compared with 33 PBS±fed mice that were scale immune deviation towards the production of regu-
used as controls. latory cytokines.
(C) Mice were fed with cyt c or PBS as described. Additional groups
of mice were similarly fed with 0.5 mg HEL in PBS. Spleen cells (2 3
Oral Administration of Cyt c Induces106) were cultured with 3 mM cyt c protein in 2.0 ml of complete RPMI
Systemic Early T Cell Activationmedium. Supernatants were assayed for lymphokine production by
T cells are sequestered at the site of antigen presenta-ELISA as described in Experimental Procedures. IL-2 production is
representative of three independent feeding experiments. Mice fed tion (Pape et al., 1997). In order to determine the sites
with cyt c protein are shown as filled bars, HEL as hatched bars, of tolerance induction, we analyzed the cyt c±specific
and PBS alone as open bars. Each bar represents data from one T cells in the spleen, MLN, Peyer's patches (PP), and
mouse. Assays with 0.1, 1, or 10 mM cyt c protein yielded similar
peripheral blood 6±72 hr after feeding a single dose ofresults (data not shown).
0.5 mg of cyt c. As shown in Figure 3, 6 hr after antigen
administration the most pronounced change is a 2-fold
reduction in the percentage of cyt c±specific cells inwere tested for the presence of IL-2, IL-4, IL-10, inter-
feron-g (IFNg), and TGFb. The amount of IL-2 produced the blood. Less dramatic but none-the-less significant
differences are seen in the MLN, where a decrease inis decreased approximately 2-fold in cultures from cyt
c±fed mice as compared to those from HEL- or PBS- the percentage of antigen-specific T cells is observed
by 6 hr, and in the spleen, where an increase in thefed mice (Figure 2C). This parallels both the reduction
in the number of cyt c/I-Ek1 cells and the proliferation percentage of antigen-specific cells can be observed.
No statistically significant changes are seen in the PP.results. The IL-4, IFNg, and IL-10 concentrations in all
cultures were below the detection limits of 1.37 3 1024 Kearney et al. (1994) have examined the effect of intra-
venous injection of OVA peptide on the number of anti-U/ml, 200 pg/ml, and 200 ng/ml respectively (data not
shown). Average TGFb production was below 0.3 ng/ml gen-specific T cells in the lymph nodes of mice adop-
tively transferred with OVA-specific transgenic T cells.and did not differ among cyt c±, PBS-, and HEL-fed
mice. They observed an increase in the number of OVA-spe-
cific cells at day 2 after injection. Based on these data,The decrease in the percentage of T cells staining
with the cyt c/I-Ek tetramer after feeding could be due the kinetics of accumulation of antigen-specific T cells
in response to orally introduced cyt c protein appear toto activation-induced cell death, TCR down-regulation,
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be at least as rapid as, if not more rapid than, those
induced by injected OVA peptide.
To assess whether T cells in systemic lymphoid or-
gans are activated by the orally administered antigen,
we made use of the observation that the cell surface
lymphocyte activation marker CD69 can be up-regu-
lated as early as 3 hr after T cells encounter antigen
(Testi et al., 1994). This readout is relatively insensitive
to costimulation requirements and has been used to
study T cells that later become either tolerized or primed
(Croft et al., 1997).
Our results show that as early as 6 hr after feeding a
single dose of 0.5 mg of cyt c protein, some of the cyt
c±specific T cells from the spleen and MLN express
CD69 (Figures 4A and 4B). Some of the CD691 antigen-
specific cells from spleen, MLN, as well as PP also show
evidence of blasting (Figure 4C) 24 hr after feeding. This
suggests that the rapidly distributed cyt c can induce
antigen-specific T cell activation in all lymphoid organs.
The percentage of antigen-specific CD691 cells peaks
at 24 hr after feeding and rapidly declines after 48 hr
(Figure 4B). The early induction and subsequent de-
crease in the number of CD691 antigen-specific T cells
are similar to those observed when either soluble cyt c
protein (data not shown) or peptides (Pearson et al.,
1997; Zhong et al., 1997) are injected intravenously.
Significantly, the induction of CD69 expression was
not observed in the tetramer-negative T cell population
at any time point from 6 to 72 hr (Figure 4A and data
not shown). This indicates that feeding cyt c does not
induce bystander activation.
Splenic Cells Can Activate Cyt c±Specific
T Cells In Vitro 6 hr After Feeding
Cyt c Protein
Since our results indicate that the orally administered
cyt c protein is rapidly distributed to and recognized in
the spleen, we tested whether these splenic cells have
the capacity to stimulate cyt c±specific T cell responses
in vitro. Mice were fed 5 mg of cyt c protein and sacri-
ficed 6 hr later, and their spleen cells were cocultured
with lymph node cells from 5C.C7 ab TCR transgenic
mice. The ability of spleen cells to stimulate cyt c±spe-
cific T cell responses was then assessed by their ability
to induce CD69 expression on 5C.C7 ab TCR transgenic
T cells. As shown in Figure 5, spleen cells from 5C.C7
b TCR transgenic mice fed with cyt c but not with PBS
were indeed able to activate 5C.C7 ab TCR transgenic
T cells (13 of 30 mice tested, as compared with 0 of 9
PBS-fed mice). This stimulation is TCR-specific, as lymph
Figure 4. Orally Administered Cyt c Induces Early T Cell Activation
in Peripheral Lymphoid Organs
(A) Representative histograms of CD69 expression on spleen cells and PI1 cells. Points represent the values from individual mice; bars
from mice sacrificed 6 hr after oral administration of 0.5 mg of cyt c represent the arithmetic means.
in PBS (b and d) or PBS alone (a and c). Cells were stained as (C) CD691 antigen-specific cells show signs of blasting 24 hr after
described in Figure 3. Cells that are positive for B220 and PI and feeding. Representative FACS analysis of spleen, MLN, and PP cells
negative for CD4 are excluded from the analysis. CD69 expression from mice sacrificed 24 hr after oral administration of 0.5 mg of
is shown separately on cells that are cyt c/I-Ek tetramer-positive cyt c in PBS (b, d, and f) or PBS alone (a, c, and e). Cells were
and negative. Similar profiles were obtained from MLN cells. stained as described in Figure 3A. Cells stained positive for CD4 and
(B) Mice were fed with 0.5 mg of cyt c in PBS and sacrificed 6, 24, the cyt c/I-Ek tetramer and negative for B220 and PI are displayed in
48, or 72 hr later or with PBS alone and sacrificed 24 or 72 hr later. the 5% probability plots. The vertical axis indicates CD69 expres-
Cells from spleen and MLN were analyzed as described in Figure sion, and the horizontal axis denotes forward scatter. Similar results
3. The percentages of antigen-specific (CD41 cyt/c I-Ek tetramer- are observed in 6 of 8 (spleen), 6 of 8 (MLN), and 4 of 4 (PP) cyt
positive) cells that are CD691 were calculated after excluding B2201 c±fed animals.
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basic principles of immune responses, foreign antigens
are seldom encountered through intravenous injection.
Our results suggest that this mechanism may occur con-
stantly as food intake occurs. Further, it has been dem-
onstrated that continued TCR stimulation is required for
T cell survival in vivo (Takeda et al., 1996; Rooke et al.,
1997; Tanchot et al., 1997). Therefore, it is possible that
the transient T cell activation induced by food antigen
may contribute to the maintainance of the peripheral T
cell population. This suggests that many food antigens
that pass through the gastrointestinal tract can have a
major impact on the immune system. Thus, our daily
diet may play a more significant role in shaping the
peripheral T cell repertoire than previously realized.
In caseswhere soluble peptide and superantigen were
injected, the antigen-mediated cell death could be
averted in certain situations. Examples include the en-
counter of antigen-presenting cells expressing proper
costimulatory molecules, a particular cytokine environ-
ment, lipopolysaccharide, or the presence of an ongoing
infection (Rocken et al., 1992, 1994; Vella et al., 1995;
Perez et al., 1997). It is conceivable that the fate of T
cells activated by orally administered antigen can also
Figure 5. Spleen Cells from Mice Fed with Cyt c Can Stimulate Cyt be influenced by such stimuli, and thus fed antigen may
c±Specific T Cells In Vitro sometimes induce rather than suppress immune re-
A single dose of 5 mg of cyt c in PBS or PBS alone was administered sponses. The recent report of Blanas et al. (1996) show-
to 5C.C7 TCRb transgenic mice. Mice were sacrificed 6 hr later, and ing that orally administered OVA can induce CD41 T
2 3 105 spleen cells were cultured alone or with 1 3 105 lymph node cell±dependent OVA-specific cytotoxic T lymphocyte
cells from 5C.C7 ab TCR transgenic mice in 200 ml of complete
responses supports this notion.RPMI medium. After a 24 hr culture period, cells were analyzed for
The experimental system we describe here allows usCD69 expression. Cells were stained with antibodies against CD69,
to further characterize the cells involved in presentingCD4, and B220. Cells that are positive for B220 and PI and negative
for CD4 are excluded from the analysis. Histograms represent CD69 orally administered antigen and to determine the extent
expression on (A) spleen cells from cyt c±fed mice cocultured with to which other stimuli can influence the fate of activated
5C.C7 TCR ab chain transgenic lymph node cells, (B) spleen cells antigen-specific CD41 cells (elimination vs. effector/
from cyt c±fed mice alone, (C) spleen cells from PBS-fedmice cocul-
memory cell development). This information should helptured with 5C.C7 TCR ab chain transgenic lymph node cells, and
us to better understand situations in which the efficiency(D) 5C.C7 TCR ab chain transgenic lymph node cells cultured with
of antigen uptake, presentation, and T cell activation0.1 mM cyt c protein. The percentage of cells that are CD691 is
indicated for each culture. are altered, as in the case of food allergies or autoinflam-
matory bowel diseases.
node cells from 3A9 ab TCR transgenic mice (specific Experimental Procedures
for HEL) in the same assay were not induced to up-
regulate CD69 (data not shown). The observation that Mice and Antigen Administration
B10.BR mice were purchased from The Jackson Laboratory (Barspleen cellscan present cyt c shortly after its oral admin-
Harbor, ME). 5C.C7 TCR b chain transgenic and TCR ab chainistration is not limited to 5C.C7 TCRb transgenic mice,
transgenic mice (Jorgensen et al., 1992; Fazekas de St. Groth, 1992)as normal B10.BR mice can also display this effect (3
and 3A9 TCR ab chain transgenic mice (Ho et al., 1994), all on the
of 9 mice tested). B10.BR background, were bred and maintained in the animal facility
In view of the fact that the spleen lacks afferent of Stanford University. Mice (8±10 weeks old) were fed by intragas-
lymphatic drainage and largely processes bloodborne tric gavage (20 gauge feeding needles) with pigeon cytochrome c
protein (Sigma) in PBS, HEL protein (Sigma) in PBS, or PBS alone.antigens, our observations suggest that the orally ad-
ministered cyt c, either intact or degraded, soluble or
Tetramer Staining Reagentcell-bound, enters the blood stream and is rapidly dis-
The cyt c/I-Ek tetramer staining reagent was made as follows. Atributed to secondary lymphoid organs, where it can
glycine±serine linker and a 13±amino acid signal sequence for bio-trigger T cell responses.
tinylation (bir A substrate peptide [BSP] sequence LHHILDAQKMVW
The most striking finding of our study is the rapid NHR [Schatz, 1993]) were introduced at the truncated C terminus
resorption, processing, and presentation of the orally of the soluble domain of the I-Ea chain by PCR using the plasmid
pBJ1-neo/MHCab (Wettstein et al., 1991) as a source of target DNA.introduced cyt c protein. The rapid T-cell activation fol-
The primers are the 59 (sense) primer CATATGGCTAGCATCAAAGAlowed by a decline in the number of antigen-specific
GGAACACACCAT and 39 (antisense) primer ccggaattcttaacgatT cells described in this report is very similar to that
gattccacaccattttctgtgcatccagaatatgatgcagGAGGAGGGTTTTCTCpreviously describedfor peripheral tolerance induced by
TTC (the capital letters correspond to sequences encoded by the
intravenous injection of soluble peptide or superantigen I-Ea chain). The gene was amplified by 3 cycles of denaturation
(MacDonald et al., 1991; Kearney et al., 1994; Rocha et (948C for 1 min), annealing (458C for 1 min), and extension (728C
for 1 min), followed by 12 cycles of denaturation (948C for 1 min),al., 1995). While these studies have shed light on the
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annealing (558C for 1 min), and extension (728C for 1 min), and (Y.-h. C. and M. M. D.), the Deutscher Akademischer Austausch-
dienst (I. G.), and the Dean's fellowship of Stanford University (I. G.finished with 7 min at 728C followed by 48C overnight. The PCR
product was digested with NheI and EcoRI and subcloned into and A. M. F.).
pGEMEX-1 (Promega). The construction of the expression plasmid
containing the soluble form of the I-Eb chain in pGEMEX-1 has been Received February 18, 1998; revised April 14, 1998.
previously described (Altman et al., 1993).
The I-Ea and b subunit proteins were produced as inclusion bod-
Referencesies in the BL21(DE3)pLysS strain of Escherichia coli. The inclusion
bodies were purified, solubilized, and folded in vitro with cyt c pep-
Altman, J.D., Reay, P.A., and Davis, M.M. (1993). Formation of func-tide (88±103) as previously described (Altman et al., 1993). The
tional peptide complexes of class II major histocompatibility com-folded cyt c/I-Ek complexes were purified on a 14-4-4 antibody
plex proteins from subunits produced in Escherichia coli. Proc. Natl.column. After buffer exchange into PBS, the cyt c/I-Ek-BSP com-
Acad. Sci. USA 90, 10330±10334.plexes were biotinylated using the bir A enzyme (Schatz, 1993) for
Altman, J.D., Moss, P.A.H., Goulder, P.J.R., Barouch, D.H.,12 hr at room temperature. The biotinylated cyt c/I-Ek heterodimers
McHeyzer-Williams, M.G., Bell, J.I., McMichael, A.J., and Davis,were size-purified using a Superdex S75 FPLC sizing column. Cyt
M.M. (1996). Phenotypic analysis of antigen-specific T lymphocytes.c/I-Ek tetramers were prepared by mixing the purified biotinylated
Science 274, 94±96.cyt c/I-Ek heterodimers with phycoerythrin-labeled strepavidin (Ul-
tralite, Molecular Probes) at a molar ratio of 4:1. Blanas, E., Carbone, F.R., Allison, J., Miller, J.F., and Heath, W.R.
(1996). Induction of autoimmune diabetes by oral administration of
autoantigen. Science 274, 1707±1709.
Flow Cytometry Bruce, M.G., and Ferguson, A. (1986). Oral tolerance to ovalbumin
For analysis, 1 3 106 cells from spleen, MLN, or PP were incubated in mice: studies of chemically modified and `biologically filtered'
with the cyt c/I-Ek tetramer (coupled with phycoerythrin) for 2 hr. In antigen. Immunology 57, 627±630.
the last 30 min of the incubation period, antibodies to CD4 (GK1.5,
Chase, M.W. (1946). Inhibition of experimental drug allergy by priorcoupled with fluorescein or allophycocyanin), CD69 (H1.2F3, fluo-
feeding of sensitizing agent. Proc. Soc. Exp. Biol. Med. 61, 257±259.rescein-coupled), and B220 (RA3-6B2, coupled with cy-chrome)
Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A., and Weiner, H.L.were added. Propidium iodine (PI) (1 mg/ml) was added in the final
(1994). Regulatory T cell clones induced by oral tolerance: suppres-wash. Cells were analyzed on a Becton Dickinson fluorescence-
sion of autoimmune encephalomyelitis. Science 265, 1237±1240.activated cell sorter (FACS) apparatus (Stanford University FACS
Facility). Events (50,000) were collected and analyzed using FloJo Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V.K., and
or Desk software (Stanford University). All profiles show data on Weiner, H.L. (1995). Peripheral deletion of antigen-reactive T cells
cells that are negative for B220 and PI (to exclude dead cells). in oral tolerance. Nature 376, 177±180.
Chen, Y., Inobe, J., Kuchroo, V.K., Baron, J.L., Janeway, C.A., Jr.,
and Weiner, H.L. (1996). Oral tolerance in myelin basic protein T-cell
Proliferation Assay receptor transgenic mice: suppression of autoimmune encephalo-
Spleen or MLN cells (2 3 105) were cultured with the indicated myelitis and dose-dependent induction of regulatory cells. Proc.
amount of cyt c protein in 200 ml of complete RPMI medium (supple- Natl. Acad. Sci. USA 93, 388±391.
mented with 10% fetal calf serum [Gemini], nonessential amino
Chen, Y., Inobe, J., and Weiner, H.L. (1997). Inductive events inacids, sodium pyruvate, penicillin, streptomycin, L-glutamine [Ap-
oral tolerance in the TCR transgenic adoptive transfer model. Cell.plied Scientific], and 2-mercaptoethanol). Proliferation was assayed
Immunol. 178, 62±68.by [3H]methyl-thymidine incorporation in the last 12 hr of an 84 hr
Croft, M., Joseph, S.B., and Miner, K.T. (1997). Partial activation ofculture period.
naive CD4 T cells and tolerance induction in response to peptide
presented by resting B cells. J. Immunol. 159, 3257±3265.
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